Lates News

Hong Kong stocks rebounded in the innovative pharmaceutical sector, with BeiGene rising nearly 7%, Rongchang Biotechnology and Xinda Biotechnology up over 4%, and Jiangsu Hengrui Medicine, Kanglong Chemical, and WuXi Biologics up over 1%.